These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 8555702)
1. Familial non-multiple endocrine neoplasia medullary thyroid carcinoma: report of a case confirming a new clinical entity in Japan. Katagiri M; Ohtawa T; Ito K; Harada T Surg Today; 1995; 25(9):822-6. PubMed ID: 8555702 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma. Allen SM; Bodenner D; Suen JY; Richter GT Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888 [TBL] [Abstract][Full Text] [Related]
3. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081 [TBL] [Abstract][Full Text] [Related]
4. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes. Skinner MA; Wells SA Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335 [TBL] [Abstract][Full Text] [Related]
5. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274 [TBL] [Abstract][Full Text] [Related]
6. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES). Niederle B; Sebag F; Brauckhoff M Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502 [TBL] [Abstract][Full Text] [Related]
7. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218 [TBL] [Abstract][Full Text] [Related]
8. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma. Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880 [TBL] [Abstract][Full Text] [Related]
10. Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A? Rone JK; Lane AG; Grinkemeyer MD Thyroid; 1998 Sep; 8(9):781-5. PubMed ID: 9777749 [TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid carcinoma in Northern Ireland, 1967-1997. Dolan SJ; Russell CF Ann R Coll Surg Engl; 2000 May; 82(3):156-61. PubMed ID: 10858675 [TBL] [Abstract][Full Text] [Related]
12. [Decision making in postoperative incidentally found small C-cell-carcinoma]. Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440 [TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103 [TBL] [Abstract][Full Text] [Related]
14. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097 [TBL] [Abstract][Full Text] [Related]
15. [Lump in the neck: 4 patients with a medullary thyroid carcinoma]. Jansen M; Jansen-Schillhorn van Veen JM; Vroom TM; van Vroonhoven TJ; Lips CJ Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2234-41. PubMed ID: 11757248 [TBL] [Abstract][Full Text] [Related]
16. Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Frilling A; Dralle H; Eng C; Raue F; Broelsch CE Surgery; 1995 Dec; 118(6):1099-103; discussion 1103-4. PubMed ID: 7491529 [TBL] [Abstract][Full Text] [Related]
17. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse]. Łacka K; Michałek K; Majewski P Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes. Wells SA; Skinner MA Exp Clin Endocrinol Diabetes; 1998; 106(1):29-34. PubMed ID: 9516056 [TBL] [Abstract][Full Text] [Related]